DRUG SELECTION FOR NON-SMALL CELL LUNG CANCER THERAPY

摘要

The present invention provides methods for selecting a suitable anticancer drag for the treatment of patient with non-small cell lung cancer (NSCLC), The present invention also provides methods for determining drug resistance in NSCLC patients receiving EGFR inhibitor therapy.